Content » Vol 85, Issue 1

Daclizumab: A Novel Therapeutic Option in Severe Bullous Pemphigoid


DOI: 10.1080/00015550410022221

Abstract

This article does not have an abstract.

Significance

Supplementary content

Comments

Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.
Advertisement